Thymosin Alpha-1 Reference
Educational, not medical advice reference for Thymosin Alpha-1: Immune, Longevity; regulatory status, evidence posture, source review, and sched…
Plain English
- What it is
- Thymosin alpha-1 is a lab-made copy of a small protein the body's own immune system makes. It is not approved by the FDA in the United States, and US regulators have restricted it as a compounding ingredient over safety concerns.
- What people use it for
- People in the peptide community use it hoping to support the immune system. They often talk about it around chronic infections, recovery after surgery, or cold and flu season. Most of that everyday immune-help use is not what the human studies actually tested.
- What the science shows
- Unlike most peptides in this space, thymosin alpha-1 has a real body of human research, including more than 30 trials and studies in hepatitis B and serious liver failure. The results are mixed and tied to specific medical conditions, so they do not prove it works for general wellness or broad immune support.
- The catch
- It is not an FDA-approved drug in the United States, and the FDA restricted it along with other peptides. The strong-sounding human trials are about specific illnesses, not everyday immune boosting, and claims about COVID-19 or cancer are not proven.
Reference summary
Compared with most peptides in this library, thymosin alpha-1 has deeper human clinical literature. Even so, indication-specific trial results are mixed and should not be generalized to broad 'immune support' use.
Regulatory and posture
- Categories
- Immune, Longevity
- Aliases
- Thymosin-alpha 1, Ta1, Zadaxin (outside US)
- Evidence posture
- human - Human data are indication-specific, not broad wellness evidence.
- Regulatory status
- No FDA-approved thymosin alpha-1 drug label in the United States. Published randomized human trials exist in hepatitis B and immune-related conditions, but US use remains investigational and FDA lists thymosin-alpha 1 among bulk substances with safety-risk concerns.
- Content review status
- research reference
Selected public sources
- FDA bulk drug substances with significant safety risks
- PubMed: thymosin alpha-1 HBV trial
- PubMed: thymosin alpha-1 ACLF trial
Related tools
- Peptide reconstitution calculator - Convert vial mass and BAC water volume into mcg/ml.
- BAC water calculator - Solve BAC water volume for a target concentration.
- Multi-dose vial calculator - Estimate doses per vial and a projected vial-empty date.
- Reconstituted-vial storage window calculator - Estimate a generic usable-window date and days remaining.
- Peptide half-life calculator - Estimate single-dose decay from cited half-life constants.
- Injection-site rotation overview - Public overview of the Pro site-rotation planner.
For research and educational purposes only. Not medical advice.